|IVTY -- USA Stock|| |
USD 3.45 0.10 2.82%
Vice President of Business Development
Mr. Joseph Guido is Vice President of Business Development of the Company, since February 2016. From 2012 to 2016, Mr. Guido served as Senior Vice President of Marketing and Business Development for Hansen Medical, a publiclytraded robotics company in the vascular and cardiac sectors. Prior to joining Hansen Medical, Mr. Guido served as the President of Heartstitch Medical, a medical devices company, in 2011. Prior to joining Heartstitch Medical, Mr. Guido held a variety of leadership roles in Marketing, Sales and Business Development for both public and private medical device companies such as Stryker Endoscopy, Intuitive Surgical, Novare Surgical and Abbott Vascular Devices
Age: 49 President Since 2016 MBA
Guido received his B.S. degree in business administration from Villanova University and his M.B.A. from Pepperdine University.
The company has return on total asset (ROA)
of (37.87) %
which means that it has lost $37.87 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (237.71) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.98 M in liabilities with Debt to Equity (D/E) ratio of 641.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity has Current Ratio of 2.5 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets. It employs 161 people.Invuity (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 161 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.
Invuity Leadership Team
|Robert Gerberich, President|
|Douglas Heigel, VP|
|Daniel Wolterman, Director|
|Alex Vayser, Founder|
|William Burke, Director, MBA|
|Philip Sawyer, CEO, MBA|
|Eric Roberts, Director|
|Andrew Sale, President|
|Scott Flora, Director|
|Gregory Brown, Executive, MBA|
|James Mackaness, CFO|
|Steve Annen, President|
|Joseph Guido, President, MBA|
|Randall Lipps, Director|
|Paul Davison, VP|
|Reza Zadno, Director, Ph.D|
|Brett Robertson, Executive|
|Gregory Lucier, Chairman, MBA|
|Marcia Fish, Executive, MBA|
Stock Performance Indicators
Macroaxis portfolio users are indifferent in their judgment towards investing in Invuity. What is your judgment towards investing in Invuity? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations